Tramaspen Sr 100 mg, 150 mg, 200 mg Sustained release tablets.
PDF Leaflet Revision Date: 27 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Management of moderate to severe pain in adults and children aged 12 years and older.
Dosage (summary)
Initial dose: 100 mg twice daily; max: 400 mg/day.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy or breastfeeding due to risks of adverse reactions.
Key Drug Interactions
- MAOIs
- CNS depressants
- Carbamazepine
Contraindications
- Hypersensitivity to tramadol or opioids
- Acute intoxication with CNS depressants
- Uncontrolled epilepsy
- Respiratory depression
Common side effects
- Nausea
- Dizziness
- Constipation
Counselling Points
- Avoid alcohol while taking this medication.
- Monitor for signs of respiratory depression.
- Do not abruptly discontinue if dependent.
Serious warnings
- Risk of respiratory depression
- Potential for abuse and dependence
- Seizure risk
Important Disclaimer
The Tramaspen Sr 100 mg, 150 mg, 200 mg Sustained release tablets. professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
